Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Cdk5 in Amyloid-beta Pathology of Alzheimer’s Disease
Tao-Tao Lu, Chengqun Wan, Wenming Yang, et al.
Current Alzheimer Research (2019) Vol. 16, Iss. 13, pp. 1206-1215
Closed Access | Times Cited: 25

Showing 25 citing articles:

Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles
Yao Qi, Lin Guo, Yibin Jiang, et al.
Drug Delivery (2020) Vol. 27, Iss. 1, pp. 745-755
Open Access | Times Cited: 164
Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases
Heena Khan, Nikhil Garg, Thakur Gurjeet Singh, et al.
Neurochemical Research (2022) Vol. 47, Iss. 5, pp. 1125-1149
Closed Access | Times Cited: 33
CEND1 deficiency induces mitochondrial dysfunction and cognitive impairment in Alzheimer’s disease
Wenting Xie, Dong Guo, Jieyin Li, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 12, pp. 2417-2428
Open Access | Times Cited: 32
Pharmacological relevance of CDK inhibitors in Alzheimer's disease
Nishtha Malhotra, Rohan Gupta, Pravir Kumar
Neurochemistry International (2021) Vol. 148, pp. 105115-105115
Closed Access | Times Cited: 35
A review on cyclin-dependent kinase 5: An emerging drug target for neurodegenerative diseases
Shivani Batra, Shagufta Jahan, Anam Ashraf, et al.
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123259-123259
Closed Access | Times Cited: 13
p27Kip1, an Intrinsically Unstructured Protein with Scaffold Properties
Debora Bencivenga, Emanuela Stampone, Domenico Roberti, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2254-2254
Open Access | Times Cited: 30
VEGF-A in serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration
Fangfang Qi, Zejie Zuo, Kaishun Hu, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4374-4389
Open Access | Times Cited: 11
Combined Catalpol and Tetramethylpyrazine Promote Axonal Plasticity in Alzheimer’s Disease by Inducing Astrocytes to Secrete Exosomes Carrying CDK5 mRNA and Regulating STAT3 Phosphorylation
Huize Chen, Chujun Deng, Zeyu Meng, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10770-10791
Closed Access | Times Cited: 4
A Cdk5 Inhibitor Restores Cognitive Function and Alleviates Type 2 Diabetes in Mice
Sangita Paul, Chandran Remya, Dileep K. Vijayan, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112200-112200
Open Access
Characterization of the plasma proteomic profile of frailty phenotype
Kristina Landino, Toshiko Tanaka, Giovanna Fantoni, et al.
GeroScience (2020) Vol. 43, Iss. 2, pp. 1029-1037
Open Access | Times Cited: 29
Two new alkaloids from Dendrobium nobile Lindl. exhibited neuroprotective activity, and dendrobine alleviated Aβ1−42‐induced apoptosis by inhibiting CDK5 activation in PC12 cells
Cheng‐Chen Zhang, Yan‐Li Kong, Mao‐Sheng Zhang, et al.
Drug Development Research (2023) Vol. 84, Iss. 2, pp. 262-274
Open Access | Times Cited: 10
Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease
Dmitrii V Eremin, Е. М. Кондаурова, Aleksander Ya Rodnyy, et al.
Biochemistry (Moscow) (2023) Vol. 88, Iss. 12-13, pp. 2023-2042
Closed Access | Times Cited: 10
Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease
Chang Qu, Qingqing Xu, Wen Yang, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 12, pp. 1526-1547
Open Access | Times Cited: 9
Alzheimer’s Disease: A Suitable Case for Treatment with Precision Medicine?
Ernest K. J. Pauwels, Gerard J. Boer
Medical Principles and Practice (2024) Vol. 33, Iss. 4, pp. 301-309
Open Access | Times Cited: 2
CDK5 as a therapeutic tool for the treatment of Alzheimer's disease: A review
Sandilya Garemilla, Richa Kumari, Rahul Kumar
European Journal of Pharmacology (2024) Vol. 978, pp. 176760-176760
Closed Access | Times Cited: 2
Dietary Spray-Dried Porcine Plasma Reduces Neuropathological Alzheimer’s Disease Hallmarks in SAMP8 Mice
Cristina Rosell‐Cardona, Christian Griñán‐Ferré, Anna Pérez‐Bosque, et al.
Nutrients (2021) Vol. 13, Iss. 7, pp. 2369-2369
Open Access | Times Cited: 17
Molecular mechanisms of Alzheimer's disease: From therapeutic targets to promising drugs
Elif Alan, Zeliha Kerry, Gülnur Sevin
Fundamental and Clinical Pharmacology (2022) Vol. 37, Iss. 3, pp. 397-427
Closed Access | Times Cited: 6
Cyclin-dependent Kinase 5 Regulates Cortical Neurotransmission and Neural Circuits Associated with Motor Control in the Secondary Motor Cortex in the Mouse
Xing Li, Hu Zhou, Pei Yang, et al.
Neuroscience (2020) Vol. 438, pp. 9-24
Closed Access | Times Cited: 6
Hyperthyroidism leads learning and memory impairment possibly via GRIN2B expression alterations
Leyla Şahin, Seval Keloğlan, Özge Selin Çevik, et al.
Brain Research (2022) Vol. 1802, pp. 148209-148209
Closed Access | Times Cited: 3
ErbB4 deficiency exacerbates olfactory dysfunction in an early-stage Alzheimer’s disease mouse model
Xianhua Deng, Xingyang Liu, Yi-Hua Wei, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 12, pp. 2497-2512
Closed Access
Cdk5 inhibition in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis suppresses neurodegeneration and extends survival
Ahwon Kim, Do‐Yeon Lee, Jung‐Joon Sung
Journal of Neurochemistry (2024)
Open Access
Identification of Novel Compounds Inhibiting the Kinase Activity of the CDK5/p25 Complex via Direct Binding to p25
Riheb Jabeur, Caroline Corbel, Pascal Loyer, et al.
Biochemistry (2023) Vol. 62, Iss. 9, pp. 1452-1463
Closed Access | Times Cited: 1
Serotonin receptors - a potential target for the treatment of Alzheimer’s disease
D. Eremin, Е. М. Кондаурова, A. Ya Rodny, et al.
Биохимия (2023) Vol. 88, Iss. 12, pp. 2399-2421
Closed Access | Times Cited: 1
Editorial: Systems Genetics of Alzheimer’s Disease: From GWAS to Disease Pathways
Keshen Li
Current Alzheimer Research (2020) Vol. 16, Iss. 13, pp. 1161-1162
Closed Access | Times Cited: 2
Amyloid PET scan diagnosis of Alzheimer’s disease in patients with multiple sclerosis: a scoping review study
Mohammad Khalafi, Amirmohammad Rezaei Rashnoudi, Farzaneh Rahmani, et al.
The Egyptian Journal of Radiology and Nuclear Medicine (2023) Vol. 54, Iss. 1
Open Access
Page 1

Scroll to top